Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Finished Goods (2022 - 2026)

HeartSciences filings provide 5 years of Finished Goods readings, the most recent being $22221.0 for Q1 2026.

  • On a quarterly basis, Finished Goods fell 1.59% to $22221.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $22221.0, a 1.59% decrease, with the full-year FY2025 number at $44069.0, up 95.16% from a year prior.
  • Finished Goods hit $22221.0 in Q1 2026 for HeartSciences, roughly flat from $22221.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $44069.0 in Q2 2025 to a low of $22221.0 in Q4 2025.
  • Median Finished Goods over the past 5 years was $28662.0 (2022), compared with a mean of $28262.7.
  • Biggest five-year swings in Finished Goods: decreased 21.22% in 2024 and later surged 95.16% in 2025.
  • HeartSciences' Finished Goods stood at $28663.0 in 2022, then decreased by 0.0% to $28662.0 in 2023, then decreased by 21.22% to $22581.0 in 2024, then dropped by 1.59% to $22221.0 in 2025, then changed by 0.0% to $22221.0 in 2026.
  • The last three reported values for Finished Goods were $22221.0 (Q1 2026), $22221.0 (Q4 2025), and $44069.0 (Q3 2025) per Business Quant data.